NM_000492.4:c.328G>C

Variant summary

Our verdict is Likely pathogenic.
+7 Likely Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 7 classification points (ACGS-UK Somatic Oncogenicity v2025). O1_ModerateO3_SupportingO5_SupportingO6_SupportingO7_SupportingO8_Supporting

The NM_000492.4(CFTR):c.328G>C (p.Asp110His) variant causes a missense change involving the alteration of a conserved nucleotide. The gene CFTR is a tumor suppressor gene (CancerMine: 18 TSG, 1 driver citations). The gene CFTR is a cancer driver gene (CancerMine: 18 TSG, 1 driver citations). The variant allele was found at a cumulative frequency of 0.0000167 (AC=27) in the gnomAD database across 1,613,670 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000611. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 9.52). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV001589600: Experimental studies have shown that this missense change affects CFTR function (PMID:11278813, 23891399)." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.D110N: Likely_pathogenic (ClinVar VariationId 553436, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.D110?: not_provided (ClinVar VariationId 53706); p.D110= (synonymous): Likely_benign (ClinVar VariationId 1730061, 1 star); p.D110E: drug_response (ClinVar VariationId 53714, 3 stars) This exact variant is curated in the UniProt human variants database as Uncertain Significance, associated with Cystic fibrosis (cf).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000018 ( 0 hom. )

Consequence

CFTR
NM_000492.4 missense

Scores

13
6

Clinical Significance

Pathogenic; drug response reviewed by expert panel P:19O:2

Conservation

PhyloP100: 9.52

Publications

89 publications found
Variant links:
Genes affected
CFTR (HGNC:1884): (CF transmembrane conductance regulator) This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017]
CFTR Gene-Disease associations (from GenCC):
  • congenital bilateral aplasia of vas deferens from CFTR mutation
    Inheritance: AR Classification: DEFINITIVE Submitted by: Natera
  • cystic fibrosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Myriad Women's Health, ClinGen, Natera, Orphanet
  • congenital bilateral absence of vas deferens
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary chronic pancreatitis
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000492.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_pathogenic. The variant received 7 points.

O1Established oncogenic variant
TSG gene: ClinVar germline P/LP ★★+ — Moderate (O1); O1 contributing sources (2.0 pts): ClinVar germline P/LP in TSG (★★★)
O3Absent or very rare in population
Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000061 — very rare (O3 supporting [+1])
O5Same location/impact as known oncogenic
Different AA at same residue with oncogenic evidence (or germline P/LP in TSG), or same AA change SCI Tier II Potential — Supporting (O5); ClinVar same-AA oncogenic/T1: false | ClinVar same-AA SCI tier: — | CGI same-AA oncogenic: false | TSG: true | ClinVar same-AA germline P/LP: false | CIViC LOF: false | ClinVar diff-AA oncogenic: false | ClinVar diff-AA germline P/LP: true
O6Computational evidence supports deleterious effect
Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect
O7Mutational hotspot or critical domain
Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 18 pathogenic, 0 benign (OR vs. background: 185.0); Variant does not impact splicing — splice-hotspot path not applicable
O8Missense constraint in gene or region
Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: -1.07 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000492.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CFTR NM_000492.4
MANE Select
HGVSc / HGVSpc.328G>Cp.Asp110His
Exon rankExon 4 of 27
missense
Prot: NP_000483.3

Ensembl Transcripts

CFTR ENST00000003084.11
TSL:1MANE Select
HGVSc / HGVSpc.328G>Cp.Asp110His
Exon rankExon 4 of 27
missense
Prot: ENSP00000003084.6UniProt: P13569-1
CFTR ENST00000699602.1
HGVSc / HGVSpc.328G>Cp.Asp110His
Exon rankExon 4 of 27
missense
Prot: ENSP00000514471.1UniProt: A0A8V8TNH2
CFTR ENST00000889206.1
HGVSc / HGVSpc.328G>Cp.Asp110His
Exon rankExon 4 of 26
missense
Prot: ENSP00000559265.1UniProt: A0ACI8SBR8

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.00000657
AC:1
Hom:0
AN:152162
Cov:32
GnomAD2 exomes
AF: 0.0000199
AC:5
AN:251100
GnomAD4 exome
AF: 0.0000178
AC:26
Hom:0
AN:1461508
Cov:31
GnomAD4 genome
AF: 0.00000657
AC:1
Hom:0
AN:152162
Cov:32
TOPMed (Bravo)
AF: 0.0000189
AC:5
Hom:0
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00
AC:0
Hom:0
AN:153998
Local & regional cohorts 1 source
Turkish Variome
AF: 0.000297
AC:2
Hom:0
AN:6724
Showing 7 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
BipEx
(Bipolar disorder (including schizoaffective))
0.0000352 128420 0.0000693 228844
Epi25
(Epilepsy)
0.000119 541958 0.0000449 366882
SCHEMA
(Schizophrenia)
0.0000129 177666 0.0000359 5139300
Showing 3 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Pathogenic; drug response
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
10
-
-
Cystic fibrosis (10)
2
-
-
CFTR-related disorder (2)
2
-
-
Cystic fibrosis;C0403814:Congenital bilateral aplasia of vas deferens from CFTR mutation (2)
1
-
-
Bronchiectasis with or without elevated sweat chloride 1 (1)
1
-
-
Cystic fibrosis;C0238339:Hereditary pancreatitis;C0403814:Congenital bilateral aplasia of vas deferens from CFTR mutation;C2749757:Bronchiectasis with or without elevated sweat chloride 1 (1)
1
-
-
Cystic fibrosis;C5924204:CFTR-related disorder (1)
1
-
-
Hereditary pancreatitis (1)
1
-
-
not specified (1)
-
-
-
ivacaftor response - Efficacy (1)
-
-
-
not provided (1)

Computational Scores

AlphaGenome AVI
Pathogenic26
AlphaMissense
Pathogenic0.64
BayesDel_addAF
Pathogenic0.45D
BayesDel_noAF
Pathogenic0.52
CADD
Pathogenic27
DANN
Uncertain1.0
DEOGEN2
Uncertain0.72D
Eigen
Pathogenic0.78
Eigen_PC
Pathogenic0.79
FATHMM_MKL
Pathogenic0.99D
GPN-Star LLR
N/A-9.9
GPN-Star score
N/A9.9
LIST_S2
Uncertain0.95D
M_CAP
Pathogenic0.87D
MetaRNN
Pathogenic0.98D
MetaSVM
Pathogenic1.1D
Mutation Taster
N/A1/99disease causing (ClinVar)
MutationAssessor
Uncertain2.1M
PhyloP100
Pathogenic9.5
popEVE
Benign-3.3
PrimateAI
Uncertain0.75T
PROVEAN
Pathogenic-6.5D
REVEL
Pathogenic0.93
Sift
Uncertain0.0020D
Sift4G
Pathogenic0.0D
Varity_R
N/A0.85
VESM-3B
Benign-7.1
Showing 27 of 27 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.